Redx Pharma Plc (REDX.L) LSE

15.00

+3.6(+31.58%)

Updated at April 30, 2024 05:28PM

Currency In GBp

Valuation

Market Cap87.08M
Enterprise Value86.67M
P/E Ratio-1.52
PEG Ratio-0.02
Price/Sales Ratio13.89
Price/Book Ratio14.97
Enterprise/Revenue13.79
Enterprise/EBITDA-1.81

Fiscal Year

Fiscal YearSeptember 30, 2023
Most Recent QuarterSeptember 30, 2023

Profitability

Profit Margin-7.89
Operating Margin-8.05

Management Effectiveness

Return On Assets-1.29
Return On Equity-1.81

Income Statement

Revenue4.2M
Revenue/Share0.01
Gross Profit3.24M
EBITDA-32.02M
Net Income-33.16M
Diluted EPS-0.1

Balance Sheet

Total Cash18.09M
Total Cash/Share0.05
Total Debt17.68M
Total Debt/Equity5.27
Current Ratio1.11
Book Value Per Share0.01

Price History

52-Week Change-46.43
52-Week High37.9
52-Week Low15
Moving Average 50 Days15.13
Moving Average 200 Days21.75

Statistics

Average Volume838,041
Shares Outstanding388.99M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A